GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

GSK PLC GSK shares slipped 1.84% to £15.75 Thursday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.91% to 8,328.72. Supported ...

Ozempic and Wegovy carry high list prices of $935.77 and $1,349.02, respectively, for a month’s supply, according to the company’s website. Most U.S. patients are covered by health insurance and would ...

(Reuters) – British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data ... 2 In both groups, the most frequently reported adverse events were pain at the injection site, fatigue, and myalgia. 2 The duration of ...